Bioiberica participates at the CPhl China fair in Shanghai, on 20-22 June, booth E1Q18
- The CPhl China 2018 fair is the most important pharmaceutical fair on active ingredients in the Asia-Pacific region
- Bioiberica will present their leading active and branded ingredients, as well as end user products for human healthcare
Bioiberica participates at one of the most important events in the Asiatic continent: the CPhI China fair. This event is attended by more than 55,000 professionals from more than 120 countries, and is being held on 20-22 June in Shanghai, People’s Republic of China.
At booth E1Q18, Bioiberica’s Heparin Science and Human Health Divisions will present the leading pharmaceutical active ingredients in which our company specializes (heparin, chondroitin sulfate, glucosamine, hyaluronic acid), in addition to branded ingredients and end-user products for joint care.
As highlighted by the organizers, this fair not only helps define business opportunities and establish new partnerships; it is also an educational platform which allows firms to learn about the latest updates in their sector. China has already become the second largest pharmaceutical market in the world and is expected to be the fastest-growing biological products market in the next decade, according to CPhI data.
Bioiberica, a firm with more than 40 years worth of experience in the development and production of biomolecules for the pharmaceutical industry, would like to invite all visitors to visit our booth to learn more about the solutions we can offer.
Related News
On a planet where natural resources are limited and there is increasing concern for the environment, the circular economy has emerged as an innovative and sustainable solution.